Discovery of anti-inflammatory physiological peptides that promote tissue repair by reinforcing epithelial barrier formation

Epithelial barriers that prevent dehydration and pathogen invasion are established by tight junctions (TJs), and their disruption leads to various inflammatory diseases and tissue destruction. However, a therapeutic strategy to overcome TJ disruption in diseases has not been established because of t...

Full description

Saved in:
Bibliographic Details
Published in:Science advances 2021-11, Vol.7 (47), p.eabj6895-eabj6895
Main Authors: Oda, Yukako, Takahashi, Chisato, Harada, Shota, Nakamura, Shun, Sun, Daxiao, Kiso, Kazumi, Urata, Yuko, Miyachi, Hitoshi, Fujiyoshi, Yoshinori, Honigmann, Alf, Uchida, Seiichi, Ishihama, Yasushi, Toyoshima, Fumiko
Format: Article
Language:English
Subjects:
Biomedicine and Life Sciences
Cell Biology
Health and Medicine
SciAdv r-articles
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epithelial barriers that prevent dehydration and pathogen invasion are established by tight junctions (TJs), and their disruption leads to various inflammatory diseases and tissue destruction. However, a therapeutic strategy to overcome TJ disruption in diseases has not been established because of the lack of clinically applicable TJ-inducing molecules. Here, we found TJ-inducing peptides (JIPs) in mice and humans that corresponded to 35 to 42 residue peptides of the C terminus of alpha 1-antitrypsin (A1AT), an acute-phase anti-inflammatory protein. JIPs were inserted into the plasma membrane of epithelial cells, which promoted TJ formation by directly activating the heterotrimeric G protein G13. In a mouse intestinal epithelial injury model established by dextran sodium sulfate, mouse or human JIP administration restored TJ integrity and strongly prevented colitis. Our study has revealed TJ-inducing anti-inflammatory physiological peptides that play a critical role in tissue repair and proposes a previously unidentified therapeutic strategy for TJ-disrupted diseases.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.abj6895